Granulomatous adenohypophysitis after interferon and ribavirin therapy

Peter Tebben, John L D Atkinson, Bernd W. Scheithauer, Dana Erickson

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Objective: To describe a case of granulomatous hypophysitis occurring after treatment with interferon alfa-2b and ribavirin for hepatitis C. Methods: Clinical, radiologic, laboratory, and pathologic assessments of a woman with granulomatous hypophysitis and interferon-induced thyroiditis are presented. Results: A 42-year-old woman with hepatitis C was treated with interferon alfa-2b and ribavirin for 5 months. She was referred after symptoms of thyrotoxicosis developed, in conjunction with laboratory and radiographic evidence of thyroiditis. During the initial evaluation, she was weak and hypotensive; biochemical evaluation showed undetectable plasma cortisol and corticotropin concentrations. Magnetic resonance imaging revealed diffuse enlargement of the pituitary gland, which encroached on but did not compress the optic chiasm. Treatment with supraphysiologic doses of prednisone resulted in clinical and radiographic improvement. Once physiologic doses of glucocorticoids were instituted, however, follow-up magnetic resonance imaging showed substantial progression of the diffuse pituitary enlargement and mild compression of the optic chiasm. Surgical debulking of the mass and histologic evaluation showed chronic, noncaseating granulomatous hypophysitis. An extensive evaluation for secondary causes of granulomatous inflammation of the pituitary revealed only an elevated angiotensin-converting enzyme level; no organisms were identified. After 2 courses of high-dose glucocorticoids, she had radiographic evidence of decreased size of the pituitary lesion but continued to have multiple anterior pituitary hormone deficiencies. Conclusion: Granulomatous hypophysitis and sarcoidosis of the pituitary are rare disorders. Hypophysitis should be considered in patients receiving interferon and ribavirin therapy who have symptoms consistent with pituitary dysfunction.

Original languageEnglish (US)
Pages (from-to)169-175
Number of pages7
JournalEndocrine Practice
Volume13
Issue number2
StatePublished - Mar 2007

Fingerprint

Ribavirin
interferon alfa-2b
Interferons
Optic Chiasm
Thyroiditis
Hepatitis C
Glucocorticoids
Magnetic Resonance Imaging
Pituitary Diseases
Anterior Pituitary Hormones
Therapeutics
Thyrotoxicosis
Peptidyl-Dipeptidase A
Pituitary Gland
Sarcoidosis
Prednisone
Adrenocorticotropic Hormone
Hydrocortisone
Hypophysitis
Inflammation

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Tebben, P., Atkinson, J. L. D., Scheithauer, B. W., & Erickson, D. (2007). Granulomatous adenohypophysitis after interferon and ribavirin therapy. Endocrine Practice, 13(2), 169-175.

Granulomatous adenohypophysitis after interferon and ribavirin therapy. / Tebben, Peter; Atkinson, John L D; Scheithauer, Bernd W.; Erickson, Dana.

In: Endocrine Practice, Vol. 13, No. 2, 03.2007, p. 169-175.

Research output: Contribution to journalArticle

Tebben, P, Atkinson, JLD, Scheithauer, BW & Erickson, D 2007, 'Granulomatous adenohypophysitis after interferon and ribavirin therapy', Endocrine Practice, vol. 13, no. 2, pp. 169-175.
Tebben P, Atkinson JLD, Scheithauer BW, Erickson D. Granulomatous adenohypophysitis after interferon and ribavirin therapy. Endocrine Practice. 2007 Mar;13(2):169-175.
Tebben, Peter ; Atkinson, John L D ; Scheithauer, Bernd W. ; Erickson, Dana. / Granulomatous adenohypophysitis after interferon and ribavirin therapy. In: Endocrine Practice. 2007 ; Vol. 13, No. 2. pp. 169-175.
@article{d1f1ba40c6344ff68ad16d9ddfa6ec19,
title = "Granulomatous adenohypophysitis after interferon and ribavirin therapy",
abstract = "Objective: To describe a case of granulomatous hypophysitis occurring after treatment with interferon alfa-2b and ribavirin for hepatitis C. Methods: Clinical, radiologic, laboratory, and pathologic assessments of a woman with granulomatous hypophysitis and interferon-induced thyroiditis are presented. Results: A 42-year-old woman with hepatitis C was treated with interferon alfa-2b and ribavirin for 5 months. She was referred after symptoms of thyrotoxicosis developed, in conjunction with laboratory and radiographic evidence of thyroiditis. During the initial evaluation, she was weak and hypotensive; biochemical evaluation showed undetectable plasma cortisol and corticotropin concentrations. Magnetic resonance imaging revealed diffuse enlargement of the pituitary gland, which encroached on but did not compress the optic chiasm. Treatment with supraphysiologic doses of prednisone resulted in clinical and radiographic improvement. Once physiologic doses of glucocorticoids were instituted, however, follow-up magnetic resonance imaging showed substantial progression of the diffuse pituitary enlargement and mild compression of the optic chiasm. Surgical debulking of the mass and histologic evaluation showed chronic, noncaseating granulomatous hypophysitis. An extensive evaluation for secondary causes of granulomatous inflammation of the pituitary revealed only an elevated angiotensin-converting enzyme level; no organisms were identified. After 2 courses of high-dose glucocorticoids, she had radiographic evidence of decreased size of the pituitary lesion but continued to have multiple anterior pituitary hormone deficiencies. Conclusion: Granulomatous hypophysitis and sarcoidosis of the pituitary are rare disorders. Hypophysitis should be considered in patients receiving interferon and ribavirin therapy who have symptoms consistent with pituitary dysfunction.",
author = "Peter Tebben and Atkinson, {John L D} and Scheithauer, {Bernd W.} and Dana Erickson",
year = "2007",
month = "3",
language = "English (US)",
volume = "13",
pages = "169--175",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "2",

}

TY - JOUR

T1 - Granulomatous adenohypophysitis after interferon and ribavirin therapy

AU - Tebben, Peter

AU - Atkinson, John L D

AU - Scheithauer, Bernd W.

AU - Erickson, Dana

PY - 2007/3

Y1 - 2007/3

N2 - Objective: To describe a case of granulomatous hypophysitis occurring after treatment with interferon alfa-2b and ribavirin for hepatitis C. Methods: Clinical, radiologic, laboratory, and pathologic assessments of a woman with granulomatous hypophysitis and interferon-induced thyroiditis are presented. Results: A 42-year-old woman with hepatitis C was treated with interferon alfa-2b and ribavirin for 5 months. She was referred after symptoms of thyrotoxicosis developed, in conjunction with laboratory and radiographic evidence of thyroiditis. During the initial evaluation, she was weak and hypotensive; biochemical evaluation showed undetectable plasma cortisol and corticotropin concentrations. Magnetic resonance imaging revealed diffuse enlargement of the pituitary gland, which encroached on but did not compress the optic chiasm. Treatment with supraphysiologic doses of prednisone resulted in clinical and radiographic improvement. Once physiologic doses of glucocorticoids were instituted, however, follow-up magnetic resonance imaging showed substantial progression of the diffuse pituitary enlargement and mild compression of the optic chiasm. Surgical debulking of the mass and histologic evaluation showed chronic, noncaseating granulomatous hypophysitis. An extensive evaluation for secondary causes of granulomatous inflammation of the pituitary revealed only an elevated angiotensin-converting enzyme level; no organisms were identified. After 2 courses of high-dose glucocorticoids, she had radiographic evidence of decreased size of the pituitary lesion but continued to have multiple anterior pituitary hormone deficiencies. Conclusion: Granulomatous hypophysitis and sarcoidosis of the pituitary are rare disorders. Hypophysitis should be considered in patients receiving interferon and ribavirin therapy who have symptoms consistent with pituitary dysfunction.

AB - Objective: To describe a case of granulomatous hypophysitis occurring after treatment with interferon alfa-2b and ribavirin for hepatitis C. Methods: Clinical, radiologic, laboratory, and pathologic assessments of a woman with granulomatous hypophysitis and interferon-induced thyroiditis are presented. Results: A 42-year-old woman with hepatitis C was treated with interferon alfa-2b and ribavirin for 5 months. She was referred after symptoms of thyrotoxicosis developed, in conjunction with laboratory and radiographic evidence of thyroiditis. During the initial evaluation, she was weak and hypotensive; biochemical evaluation showed undetectable plasma cortisol and corticotropin concentrations. Magnetic resonance imaging revealed diffuse enlargement of the pituitary gland, which encroached on but did not compress the optic chiasm. Treatment with supraphysiologic doses of prednisone resulted in clinical and radiographic improvement. Once physiologic doses of glucocorticoids were instituted, however, follow-up magnetic resonance imaging showed substantial progression of the diffuse pituitary enlargement and mild compression of the optic chiasm. Surgical debulking of the mass and histologic evaluation showed chronic, noncaseating granulomatous hypophysitis. An extensive evaluation for secondary causes of granulomatous inflammation of the pituitary revealed only an elevated angiotensin-converting enzyme level; no organisms were identified. After 2 courses of high-dose glucocorticoids, she had radiographic evidence of decreased size of the pituitary lesion but continued to have multiple anterior pituitary hormone deficiencies. Conclusion: Granulomatous hypophysitis and sarcoidosis of the pituitary are rare disorders. Hypophysitis should be considered in patients receiving interferon and ribavirin therapy who have symptoms consistent with pituitary dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=34447338624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447338624&partnerID=8YFLogxK

M3 - Article

C2 - 17490932

AN - SCOPUS:34447338624

VL - 13

SP - 169

EP - 175

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - 2

ER -